ASX - Delayed Quote AUD

Chimeric Therapeutics Limited (CHM.AX)

Compare
0.0100 +0.0010 (+11.11%)
At close: October 25 at 4:10 PM GMT+11

Research Analysis

Revenue vs. Earnings

Revenue -1.76M
Earnings -7.49M
?

Analyst Price Targets

Earnings Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts ----11
Avg. Estimate --------
Low Estimate --------
High Estimate --------
Year Ago Sales --------
Sales Growth (year/est) --------

Earnings History

CURRENCY IN USD
EPS Est. --
EPS Actual --
Difference --
Surprise % --

EPS Trend

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate 0000
7 Days Ago 00-0.050
30 Days Ago 00-0.050
60 Days Ago 00-0.050
90 Days Ago 00-0.050

EPS Revisions

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD CHM.AXIndustrySectorS&P 500
Current Qtr. ------4.50%
Next Qtr. ------9.60%
Current Year ------2.10%
Next Year ------12.90%
Next 5 Years (per annum) ------11.76%
Past 5 Years (per annum) --------

Related Tickers